Business Wire (Apr 22, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
92 people get CRMD articles and Market Currents by email alert.
Get email alerts on CRMD »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (Apr 11, 2013)
-
Business Wire (Mar 27, 2013)
-
Business Wire (Feb 7, 2013)
-
Business Wire (Dec 24, 2012)
-
Business Wire (Nov 14, 2012)
-
-
Business Wire (Oct 11, 2012)
-
Business Wire (Sep 25, 2012)
-
Business Wire (Jul 2, 2012)
-
Business Wire (Jun 14, 2012)
-
Business Wire (May 3, 2012)
-
Business Wire (Apr 24, 2012)
-
Business Wire (Mar 19, 2012)
-
-
Business Wire (Dec 30, 2011)
-
-
To learn more about Seeking Alpha Pro, click here.
-
Business Wire (Apr 22, 2013)
-
Business Wire (Apr 11, 2013)
-
Business Wire (Mar 27, 2013)
-
Business Wire (Feb 7, 2013)
-
Business Wire (Dec 24, 2012)
-
Business Wire (Nov 14, 2012)
-
Business Wire (Oct 11, 2012)
-
Business Wire (Sep 25, 2012)
-
Business Wire (Jul 2, 2012)
-
Business Wire (Jun 14, 2012)
-
Business Wire (May 3, 2012)
-
Business Wire (Apr 24, 2012)
-
Business Wire (Mar 19, 2012)
-
Business Wire (Dec 30, 2011)
CRMD vs. ETF Alternatives
Company Description
Currently, there's no company description for CRMD.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Friday, January 11, 5:07 PM CorMedix (CRMD) files a shelf registration to sell, from time to time, up to 3,782,857 shares of its common stock on behalf of selling shareholders. CRMD will not receive proceeds from the secondary offering. Comment! [Healthcare]
- Thursday, October 11, 2012, 11:45 AM CorMedix (CRMD +6.7%) takes a step towards achieving compliance with European regulatory requirements, saying that it's successfully passed the ISO 13485:2003 certification. The ISO 13485 is a globally recognized standard that outlines consistent international processes for the design and manufacturing of medical devices. The company anticipates a final review and determination of its CE Mark application by the end of Q4. Comment! [Healthcare, On the Move]